BBOT (STOCKS)

    BridgeBio Oncology Therapeutics, Inc. Common Stock

    $2.950000
    +0.045000 (+1.55%)
    Prev close: $2.905000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Pedro J. Beltran
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $235.71M
    Employees
    92
    P/E (TTM)
    —
    P/B (TTM)
    0.72
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —

    Analyst Recommendations
    6
    Strong Buy
    10
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    $-0.71 $-0.58 -0.1334 -23.14%
    Mar 2026 (Q1)
    $-0.53 $-0.54 +0.0075 +1.40%
    Dec 2025 (Q4)
    $-0.49 $-0.53 +0.0375 +7.11%
    Sep 2025 (Q3)
    $-1.03 $-0.40 -0.6324 -159.05%